Cytidine 51-diphosphocholine (Citicoline) in glaucoma: Rationale of its use, current evidence and future perspectives

Gloria Roberti, Lucia Tanga, Manuele Michelessi, Luciano Quaranta, Vincenzo Parisi, Gianluca Manni, Francesco Oddone

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cytidine 51-diphosphocholine or citicoline is an endogenous compound that acts in the biosynthetic pathway of phospholipids of cell membranes, particularly phosphatidylcholine, and it is able to increase neurotrasmitters levels in the central nervous system. Citicoline has shown positive effects in Parkinson’s disease and Alzheimer’s disease, as well as in amblyopia. Glaucoma is a neurodegenerative disease currently considered a disease involving ocular and visual brain structures. Neuroprotection has been proposed as a valid therapeutic option for those patients progressing despite a well-controlled intraocular pressure, the main risk factor for the progression of the disease. The aim of this review is to critically summarize the current evidence about the effect of citicoline in glaucoma.

Original languageEnglish
Pages (from-to)28401-28417
Number of pages17
JournalInternational Journal of Molecular Sciences
Volume16
Issue number12
DOIs
Publication statusPublished - Nov 30 2015

Fingerprint

Cytidine Diphosphate Choline
glaucoma
Cytidine
Glaucoma
Amblyopia
intraocular pressure
Biosynthetic Pathways
Parkinson disease
Neurodegenerative diseases
Phosphatidylcholines
Intraocular Pressure
Neurodegenerative Diseases
central nervous system
Parkinson Disease
Disease Progression
Phospholipids
Alzheimer Disease
Neurology
Cell membranes
Central Nervous System

Keywords

  • Citicoline
  • Glaucoma
  • Neuroprotection
  • Retinal ganglion cells

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications

Cite this

Cytidine 51-diphosphocholine (Citicoline) in glaucoma : Rationale of its use, current evidence and future perspectives. / Roberti, Gloria; Tanga, Lucia; Michelessi, Manuele; Quaranta, Luciano; Parisi, Vincenzo; Manni, Gianluca; Oddone, Francesco.

In: International Journal of Molecular Sciences, Vol. 16, No. 12, 30.11.2015, p. 28401-28417.

Research output: Contribution to journalArticle

@article{6f99448de216425388237d59f9f855bf,
title = "Cytidine 51-diphosphocholine (Citicoline) in glaucoma: Rationale of its use, current evidence and future perspectives",
abstract = "Cytidine 51-diphosphocholine or citicoline is an endogenous compound that acts in the biosynthetic pathway of phospholipids of cell membranes, particularly phosphatidylcholine, and it is able to increase neurotrasmitters levels in the central nervous system. Citicoline has shown positive effects in Parkinson’s disease and Alzheimer’s disease, as well as in amblyopia. Glaucoma is a neurodegenerative disease currently considered a disease involving ocular and visual brain structures. Neuroprotection has been proposed as a valid therapeutic option for those patients progressing despite a well-controlled intraocular pressure, the main risk factor for the progression of the disease. The aim of this review is to critically summarize the current evidence about the effect of citicoline in glaucoma.",
keywords = "Citicoline, Glaucoma, Neuroprotection, Retinal ganglion cells",
author = "Gloria Roberti and Lucia Tanga and Manuele Michelessi and Luciano Quaranta and Vincenzo Parisi and Gianluca Manni and Francesco Oddone",
year = "2015",
month = "11",
day = "30",
doi = "10.3390/ijms161226099",
language = "English",
volume = "16",
pages = "28401--28417",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "12",

}

TY - JOUR

T1 - Cytidine 51-diphosphocholine (Citicoline) in glaucoma

T2 - Rationale of its use, current evidence and future perspectives

AU - Roberti, Gloria

AU - Tanga, Lucia

AU - Michelessi, Manuele

AU - Quaranta, Luciano

AU - Parisi, Vincenzo

AU - Manni, Gianluca

AU - Oddone, Francesco

PY - 2015/11/30

Y1 - 2015/11/30

N2 - Cytidine 51-diphosphocholine or citicoline is an endogenous compound that acts in the biosynthetic pathway of phospholipids of cell membranes, particularly phosphatidylcholine, and it is able to increase neurotrasmitters levels in the central nervous system. Citicoline has shown positive effects in Parkinson’s disease and Alzheimer’s disease, as well as in amblyopia. Glaucoma is a neurodegenerative disease currently considered a disease involving ocular and visual brain structures. Neuroprotection has been proposed as a valid therapeutic option for those patients progressing despite a well-controlled intraocular pressure, the main risk factor for the progression of the disease. The aim of this review is to critically summarize the current evidence about the effect of citicoline in glaucoma.

AB - Cytidine 51-diphosphocholine or citicoline is an endogenous compound that acts in the biosynthetic pathway of phospholipids of cell membranes, particularly phosphatidylcholine, and it is able to increase neurotrasmitters levels in the central nervous system. Citicoline has shown positive effects in Parkinson’s disease and Alzheimer’s disease, as well as in amblyopia. Glaucoma is a neurodegenerative disease currently considered a disease involving ocular and visual brain structures. Neuroprotection has been proposed as a valid therapeutic option for those patients progressing despite a well-controlled intraocular pressure, the main risk factor for the progression of the disease. The aim of this review is to critically summarize the current evidence about the effect of citicoline in glaucoma.

KW - Citicoline

KW - Glaucoma

KW - Neuroprotection

KW - Retinal ganglion cells

UR - http://www.scopus.com/inward/record.url?scp=84949008742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949008742&partnerID=8YFLogxK

U2 - 10.3390/ijms161226099

DO - 10.3390/ijms161226099

M3 - Article

AN - SCOPUS:84949008742

VL - 16

SP - 28401

EP - 28417

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

ER -